140 related articles for article (PubMed ID: 7660645)
1. Mild course of fetal RhD haemolytic disease due to maternal alloimmunisation to paternal HLA class I and II antigens.
Eichler H; Zieger W; Neppert J; Kerowgan M; Melchert F; Goldmann SF
Vox Sang; 1995; 68(4):243-7. PubMed ID: 7660645
[TBL] [Abstract][Full Text] [Related]
2. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
[TBL] [Abstract][Full Text] [Related]
4. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN.
Neppert J; v Witzleben-Schürholz E; Zupanska B; Bartz L; Greve O; Eichler H; Kerowgan M; Wichmann MG
Eur J Haematol; 1999 Aug; 63(2):120-5. PubMed ID: 10480291
[TBL] [Abstract][Full Text] [Related]
5. Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.
Lee J; Romero R; Xu Y; Miranda J; Yoo W; Chaemsaithong P; Kusanovic JP; Chaiworapongsa T; Tarca AL; Korzeniewski SJ; Hassan SS; Than NG; Yoon BH; Kim CJ
Am J Reprod Immunol; 2013 Aug; 70(2):162-75. PubMed ID: 23841577
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and functional asessment of anti-RhD: a comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease.
Filbey D; Garner SF; Hadley AG; Shepard SL
Acta Obstet Gynecol Scand; 1996 Feb; 75(2):102-7. PubMed ID: 8604593
[TBL] [Abstract][Full Text] [Related]
7. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
Hyland CA; O'Brien H; Flower RL; Gardener GJ
Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
[TBL] [Abstract][Full Text] [Related]
9. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
[TBL] [Abstract][Full Text] [Related]
10. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
[TBL] [Abstract][Full Text] [Related]
11. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn.
Kapur R; Della Valle L; Sonneveld M; Hipgrave Ederveen A; Visser R; Ligthart P; de Haas M; Wuhrer M; van der Schoot CE; Vidarsson G
Br J Haematol; 2014 Sep; 166(6):936-45. PubMed ID: 24909983
[TBL] [Abstract][Full Text] [Related]
12. RhD haemolytic disease of the fetus and the newborn.
Urbaniak SJ; Greiss MA
Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
[TBL] [Abstract][Full Text] [Related]
13. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
Gottvall T; Hildén JO
Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
[TBL] [Abstract][Full Text] [Related]
14. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between maternal HL-A immunization and familial prognosis of haemolytic disease of the newborn due to Rh incompatibility].
Malinvaud G; Gualde N
Rev Fr Transfus Immunohematol; 1975 Sep; 18(3):269-80. PubMed ID: 821129
[TBL] [Abstract][Full Text] [Related]
16. Maternal red blood cell alloimmunisation in south western Uganda.
Natukunda B; Mugyenyi G; Brand A; Schonewille H
Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
[TBL] [Abstract][Full Text] [Related]
17. Haemolytic disease of the fetus and newborn.
de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
[TBL] [Abstract][Full Text] [Related]
18. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the monocyte chemiluminescent response to anti-D-sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn.
Shepard SL; Noble AL; Filbey D; Hadley AG
Vox Sang; 1996; 70(3):157-63. PubMed ID: 8740008
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriage.
Bartel G; Walch K; Wahrmann M; Pils S; Küssel L; Polterauer S; Tempfer C; Böhmig GA
Hum Immunol; 2011 Feb; 72(2):187-92. PubMed ID: 21075157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
